172 related articles for article (PubMed ID: 38382808)
1. Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract-What Have We Learned in the Last Decade?
Wang XG; Yin WH; Wang HY
Lab Invest; 2024 Apr; 104(4):102028. PubMed ID: 38382808
[TBL] [Abstract][Full Text] [Related]
2. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update.
Matnani R; Ganapathi KA; Lewis SK; Green PH; Alobeid B; Bhagat G
Hematol Oncol; 2017 Mar; 35(1):3-16. PubMed ID: 27353398
[TBL] [Abstract][Full Text] [Related]
3. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update.
van Vliet C; Spagnolo DV
Pathology; 2020 Jan; 52(1):128-141. PubMed ID: 31727264
[TBL] [Abstract][Full Text] [Related]
4. Disease Progression in a Patient With Indolent T-Cell Lymphoproliferative Disease of the Gastrointestinal Tract.
Perry AM; Bailey NG; Bonnett M; Jaffe ES; Chan WC
Int J Surg Pathol; 2019 Feb; 27(1):102-107. PubMed ID: 29986618
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal T- and NK-cell lymphomas and indolent lymphoproliferative disorders.
Soderquist CR; Bhagat G
Semin Diagn Pathol; 2020 Jan; 37(1):11-23. PubMed ID: 31522873
[TBL] [Abstract][Full Text] [Related]
6. Indolent T-Cell Lymphoproliferative Disease of the GI Tract: Insights for Better Diagnosis, Prognosis, and Appropriate Therapy.
Küçük C; Wei L; You H
Front Oncol; 2020; 10():1276. PubMed ID: 32850389
[TBL] [Abstract][Full Text] [Related]
7. Indolent NK-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract - a Report of two Cases of a new Provisional Entity on the World Health Organization Classification of Hematolymphoid Tumors.
Alves de Castro JV; Costa FD; Ferreira CR
Int J Surg Pathol; 2023 Aug; 31(5):596-599. PubMed ID: 35903908
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic approach to T- and NK-cell lymphoproliferative disorders in the gastrointestinal tract.
Susan SH; Ng SB; Wang S; Tan SY
Semin Diagn Pathol; 2021 Jul; 38(4):21-30. PubMed ID: 34016481
[TBL] [Abstract][Full Text] [Related]
9. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
10. Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas.
Montes-Moreno S; King RL; Oschlies I; Ponzoni M; Goodlad JR; Dotlic S; Traverse-Glehen A; Ott G; Ferry JA; Calaminici M
Virchows Arch; 2020 May; 476(5):667-681. PubMed ID: 31773249
[TBL] [Abstract][Full Text] [Related]
11. New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.
Quintanilla-Martinez L; Swerdlow SH; Tousseyn T; Barrionuevo C; Nakamura S; Jaffe ES
Virchows Arch; 2023 Jan; 482(1):227-244. PubMed ID: 36216980
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and molecular features of indolent natural killer-cell lymphoproliferative disorder of the gastrointestinal tract.
Yi H; Li A; Ouyang B; Da Q; Dong L; Liu Y; Xu H; Zhang X; Zhang W; Jin X; Gu Y; Wang Y; Liu Z; Wang C
Histopathology; 2023 Mar; 82(4):567-575. PubMed ID: 36494712
[TBL] [Abstract][Full Text] [Related]
13. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
[TBL] [Abstract][Full Text] [Related]
14. Lymph node involvement by enteropathy-like indolent NK-cell proliferation.
Dargent JL; Tinton N; Trimech M; de Leval L
Virchows Arch; 2021 Jun; 478(6):1197-1202. PubMed ID: 32696224
[TBL] [Abstract][Full Text] [Related]
15. Primary Gastrointestinal T-Cell Lymphoma and Indolent Lymphoproliferative Disorders: Practical Diagnostic and Treatment Approaches.
Nishimura MF; Nishimura Y; Nishikori A; Yoshino T; Sato Y
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830926
[TBL] [Abstract][Full Text] [Related]
16. Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders.
Oishi N; Ahmed R; Feldman AL
Curr Hematol Malig Rep; 2023 Dec; 18(6):252-263. PubMed ID: 37870698
[TBL] [Abstract][Full Text] [Related]
17. Extranodal T- and NK-cell lymphomas.
de Leval L; Feldman AL; Pileri S; Nakamura S; Gaulard P
Virchows Arch; 2023 Jan; 482(1):245-264. PubMed ID: 36336765
[TBL] [Abstract][Full Text] [Related]
18. Indolent T-cell lymphoproliferative disorder of gastrointestinal tract with unusual clinical courses: report of 6 cases and literature review.
Fan W; Niu L; He H; Yuan J; Yuan F; Shi X; Wang Y; Chen M; Huang M; Zhou F; Xu J; Chen Q
Virchows Arch; 2023 Apr; 482(4):729-743. PubMed ID: 36472661
[TBL] [Abstract][Full Text] [Related]
19. An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow.
Wang X; Ng CS; Chen C; Yu G; Yin W
Diagn Pathol; 2018 Oct; 13(1):82. PubMed ID: 30342536
[TBL] [Abstract][Full Text] [Related]
20. Lymphomas and Amyloid in the Gastrointestinal Tract.
Ware AD; Wake LM; Fedoriw Y
Surg Pathol Clin; 2023 Dec; 16(4):719-743. PubMed ID: 37863562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
